CK-164

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCK-164
Drug Alias NameCK-164
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTexas A&M University System
Active IndicationsN/A
Inactive IndicationsUveitis

Other Information

ATC CodeN/A
Related LinksN/A